Organic Process Research and Development p. 608 - 615 (2021)
Update date:2022-08-04
Topics:
Connor, Christina G.
Deforest, Jacob C.
Dietrich, Phil
Do, Nga M.
Doyle, Kevin M.
Eisenbeis, Shane
Greenberg, Elizabeth
Griffin, Sarah H.
Jones, Brian P.
Jones, Kris N.
Karmilowicz, Michael
Kumar, Rajesh
Lewis, Chad A.
McInturff, Emma L.
McWilliams, J. Christopher
Mehta, Ruchi
Nguyen, Bao D.
Rane, Anil M.
Samas, Brian
Sitter, Barbara J.
Ward, Howard W.
Webster, Mark E.
The development of a commercial route toward the JAK1 inhibitor abrocitinib is described. The application of a late-stage Lossen rearrangement provided the desired cis-diaminocyclobutane, which was subsequently sulfonylated using a novel water-tolerable triazole sulfonylating reagent to provide the active pharmaceutical ingredient.
View MoreABA Chemicals (Shanghai) Limited
Contact:021- 5115 9199-232
Address:Suite 18D, #201 Ningxia Road,
Changzhou Screw International Trading Co., Ltd.
Contact:13906149256,18001495888
Address:Jiangsu,Jintanqu
Taixing Joxin Bio-tec Co.,Ltd.
website:http://www.joxbio.com
Contact:86-523-87558858 87612088
Address:No.88, chengdong industrial park
Taizhou Huading Chemical Co.,Ltd(expird)
Contact:+86-576-88583898
Address:Economic&Technology development zone,Taizhou City,Zhejiang Province,China
NINGBO PANGS CHEM INT’L CO., LTD.
Contact:+86-0574-27666801
Address:Floor 21, Building 11, Xintiandi, No. 689, Shijiroad, Ningbo, Zhejiang, China
Doi:10.1021/ja00179a050
(1990)Doi:10.1039/c39900000706
(1990)Doi:10.1016/S0040-4039(01)98006-2
(1970)Doi:10.1002/1521-4184(200211)335:8<363::AID-ARDP363>3.0.CO;2-S
(2002)Doi:10.1007/s00706-015-1529-1
(2016)Doi:10.1055/s-0030-1258448
(2011)